Abdul Ezaz Mutlib
Chief Scientific & Strategy Officer and President of Frontage Laboratories of CanadaDr. Abdul Ezaz Mutlib, Ph.D. serves as Chief Scientific and Strategy Officer of Frontage Holdings Corporation since January 06, 2025 and serves as its President of Frontage Laboratories of Canada since July 2025 and was its Chief Executive Officer since January 3, 2023 until January 06, 2025. He has years of R&D experience in large pharmaceutical and CRO and will play a key role in establishing Frontage as a key partner and service provider to the rapidly growing biotech industry across Canada. He had been Global Head of DMPK/Preclinical Services at Frontage Holdings Corporation since December 2022 until January 3, 2023. He was an Executive Vice President of DMPK services at Frontage Holdings Corporation since June 2017 until December 2022. From April 2010 to December 2017, he was the vice president of Frontage Labs. Before joining Frontage Holdings Corp, he was a director of Wyeth Pharmaceuticals, Inc/Pfizer Inc. Prior to that, he was an associate director of Pfizer Global Research and Development Ann Arbor Laboratories, United States, a senior research associate of DuPont Pharmaceuticals and a research associate of Hoechst-Roussell Pharmaceuticals Company. He did did his postdoctoral fellowships at Universities of Washington (UW).He was a postdoctoral fellowship at the University of British Columbia, Canada. Dr. Mutlib received his bachelor’s degree in pharmacy and his PhD degree in pharmaceutical chemistry from the University of Sydney, Australia in 1983 and 1987, respectively. Dr. Mutlib has been a member of the American Society for Mass Spectrometry since 1990. He has also received numerous awards, including the DuPont Merck Summit Award in 1997 and the Wyeth Team of the Year Award (Quantitative NMR Leader) in 2009. He is also an author of numerous scientific articles and an owner of four patents.
Positions
- Company NameFrontage Holdings CorporationStock Code01521PositionChief Scientific & Strategy Officer and President of Frontage Laboratories of Canada
